Lun - Ven 8:00 - 17:00
Vasc Health Risk Manag 2008;4(6):1459–1466.
| Benefit | Evidence Basis | Notes |
|---|---|---|
| Improved Sexual Desire | Some clinical trial results | Off-label use |
| Increased Blood Flow | Pharmacological action | May assist certain sexual dysfunctions |
| Long Duration of Effect | Pharmacokinetics | Allows for flexible timing |
| Possible Treatment for Pulmonary Hypertension | Approved in men, off-label in women | Research ongoing |
Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.
The correlated variables compete for explaining the change in 6MWD, which may result in variables losing significance compared with the univariate analysis. Prior studies have demonstrated significant effects of cotreatment with bosentan and PDE-5 inhibitors on change in 6MWD.3,28,29 To examine these correlations, a backward model selection was performed, which demonstrated that changes in 6MWD are best explained by age, etiology of PAH, WHO functional class, and baseline 6MWD. It can be noted that sex was marginally significant in this patient cohort but that background therapy with bosentan and race were not. Our study demonstrated a trend toward more progressive worsening in postmenopausal females on the basis of change from baseline 6MWD. Interestingly, this trend was not seen for males in the same age groups, suggesting that this progressive female worsening is not necessarily due to age.
Postmenopausal females may likely have more comorbidities than younger women, which may in part account for this trend. This trend may also be related to the low circulating levels of cardioprotective estrogen present after menopause and the estrogen-dependent mechanism of PDE-5 inhibitors.20,30 Ovariectomized mice that were treated with sildenafil did not experience the antiremodeling properties that their ovary-retaining counterparts did and, interestingly, after exogenous estrogen replacement regained benefit from sildenafil.20 On the basis of these animal data and the findings of our study, it appears that the treatment mechanism of PDE-5 inhibitors in women may require estrogen. This raises the question of whether PDE-5 inhibitors should be the optimal therapy for postmenopausal women. Limitations of this study include inconsistencies in tadalafil dosing and bosentan background therapy. In addition, information on hormone replacement therapy and hormone-based contraceptive use in this patient cohort was not available.
The assumption of menopausal status was based on age, and no actual information on patients’ menopausal status was available at the time of this study. The use of 6MWD as a primary end point and the short duration of the PHIRST study also present potential limitations. 6MWD should be viewed as an intermediate end point; further research into the impact of sex and menopausal status on the effects of PDE-5 inhibitors on mortality and morbidity is required.31,32 In conclusion, while PAH is a disorder with a known female and postmenopausal predominance, it appears that males and premenopausal females may experience greater functional improvement when treated with tadalafil than older women. No consistent effect of sex or menopause on TCW was observed. All subjects regardless of sex or age demonstrated improvement with tadalafil compared with placebo. Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension. Estradiol-induced attenuation of pulmonary hypertension is not associated with altered eNOS expression.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 40mg | 30 + 4 Pills | 74.97€ 71.40€ | |
| Cialis Generic | 2.5mg | 10 Pills | 28.51€ 27.15€ | |
| Cialis Generic | 60mg | 90 + 6 Pills | 196.67€ 187.30€ | |
| Cialis Generic | 10mg | 10 Pills | 31.41€ 29.91€ | |
| Tadalista Super Active | 20mg | 270 + 30 Pills | 661.49€ 629.99€ | |
| Cialis Generic | 5mg | 10 Pills | 29.39€ 27.99€ | |
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Cialis Generic | 2.5mg | 30 + 4 Pills | 51.95€ 49.48€ | |
| Tadalista Super Active | 20mg | 90 + 10 Pills | 314.14€ 299.18€ | |
| Cialis Generic | 60mg | 60 + 4 Pills | 145.06€ 138.15€ | |
| Cialis Generic | 10mg | 180 + 8 Pills | 236.88€ 225.60€ |
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials.
These additional findings with regard to sex and estimated menopausal status provide clinicians with further information that can be used to individualize treatment for patients. The abstract was published under the title “Gender Differences in Response to PAH Therapy: 6MWD and Time to Clinical Worsening” in the International Society of Heart and Lung Transplant Annual Meeting poster session on April 25, 2013. Source of Support: HCC receives research support from National Heart, Lung, and Blood Institute grants P01 HL-103455, U01 HL-108642, R34 HL-117344, and RO1 HL-11475; the Vascular Medicine Institute; the Institute for Transfusion Medicine; and the Hemophilia Center of Western Pennsylvania. Conflict of Interest: YR and JC are employed by United Therapeutics. 2.Humbert M, Sitbon O, Simonneau G.
Treatment of pulmonary arterial hypertension. ; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group. Sex differences in the diagnosis, treatment, and outcome of patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Increased mortality in African Americans with idiopathic pulmonary arterial hypertension.
8.Rabinovitch tadalafil 2 5 mg M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. 9.Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA 3rd. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease. Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.
Couple sexual dysfunction is a common, but not often studied, problem.
Sex differences in response to tadalafil in pulmonary arterial hypertension. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. 17.Lahm T, Patel KM, Crisostomo PR, Markel TA, Wang M, Herring C, Meldrum DR. Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury.
PDE5 inhibitor efficacy is estrogen dependent in female heart disease. Pulmonary arterial hypertension in France: results from a national registry. 23.English KM, Jones tadalafil 60mg uk RD, Jones TH, Morice AH, Channer KS. Gender differences in the vasomotor effects of different steroid hormones in rat pulmonary and coronary arteries. 24.Beretta L, Caronni M, Origgi L, Ponti A, Santaniello A, Scorza R.
Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Evidence for a difference in nitric oxide biosynthesis between healthy women and men. 27.Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS, Jones RD. Characterization of the vasodilatory action of testosterone in the human pulmonary circulation. We have previously reported that disturbance in the relational domain, as measured by SIEDY Scale 2 (exploring, as reported by the patient, menopausal symptoms, partner's medical illness interfering with sexual activity, and reduced partner desire and climax), is associated with different sexual dysfunctions, such as hypoactive sexual desire, erectile dysfunction (ED), delayed ejaculation, and psychological disturbances.
For tadalafil-treated patients, the log-rank test did not show a consistent age-dependent effect on TCW in females (P = 0.78). In this sex-based post hoc analysis of the PHIRST study that assessed the effect of tadalafil in patients with PAH, we found a significant difference between the sexes in 6MWD change but no consistent effect of sex on TCW. This difference in 6MWD was not significant in the multivariate analysis. In the female population, a trend was found for greater improvement in 6MWD for premenopausal compared with postmenopausal women. This menopausal status trend was not present for TCW.
The baseline characteristics were fairly similar between males and females, with a significant difference in PAH etiology, age, and weight. The female cohort reported more atrial septal defects and was slightly younger than the male cohort. Body mass index data were missing for most patients in this study; therefore, it is unclear whether the weight difference between the sexes is physiologically significant. Female patients were grouped according to age as a surrogate marker for menopausal status; significant differences between the age groups in the distribution of PAH etiology and in 6MWD at baseline were noted. It is unclear how significant the etiology distribution was to the overall results, since the majority of each age group consisted of women with idiopathic PAH.
The difference in baseline 6MWD did reveal a significantly lower 6MWD for older women, which was considered when evaluating change in 6MWD. Our data indicate that males treated with tadalafil may have a clinically significant functional improvement compared with females, supporting the findings of the recently published tadalafil sex-response study.12 The authors of that study suggested that this was due to male patients having lower levels of NO and, therefore, a more robust response to the enhanced NO signaling resulting from PDE-5 inhibition.12,26 Testosterone may also play an important role given its pulmonary vasodilator action via inhibition of the L-type voltage-gated calcium channel.27 It seems likely that the observed difference in functional improvement between the sexes in this study is due 10 mg tadalafil to the multifactorial effects of testosterone and estrogen on the pulmonary vasculature. The difference in 6MWD between the sexes for those treated with tadalafil was statistically significant by the nonparametric Wilcoxon rank sum test. After controlling for multiple variables, including age, sex, race, etiology of PAH, WHO functional class, baseline 6MWD, and background therapy with bosentan, the observed differences in 6MWD between the sexes was no longer statistically significant. This may be due to correlation of variables in the multivariate regression model. As all of these symptoms could be associated with hypogonadism, we have investigated the possible relationship between androgen levels and an unhappy couple relationship.
Années d'expérience
Domaines d'interventions
Dans le cadre de notre stratégie, nous menons des actions locales dans les différentes écorégions cruciales, en visant des objectifs globaux.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Parce que chaque espèce joue un rôle particulier dans l’écosystème, elle est précieuse
En savoir plus
L'éducation environnementale sensibilise, surtout les jeunes, à nos ressources et à leur usage durable.
En savoir plus
L'écotourisme préserve la nature, implique les communautés locales et offre des expériences durables.
En savoir plus
Moins dépendance forestière, plus de sécurité alimentaire, préservation des ressources.
En savoir plusNos Projets
ODDB-ONG mène des actions écologiques pour soutenir les populations locales dans leurs efforts pour améliorer leur bien-être et celui de leur environnement.
Nous voulons nous assurer que les espèces les plus emblématiques et les plus menacées soient préservées et puissent évoluer librement dans la nature. Nous plaidons également pour le renforcement de l'intégrité de nos forêts les plus importantes et des avantages qu'elles procurent en termes de bien-être. Nous nous battons également pour que les futurs systèmes alimentaires soient durables et conformes aux critères de santé alimentaire. Enfin, il est nécessaire d'opérer une transition mondiale vers un avenir à faible émission de carbone.
Question à nous poser
Nos Statistiques
Années d'expérience
de superficies reboisées
personnes sensibilisées
personnes autonomisées
Stagiaires et bénévoles formés pour suivi de la biodiversité
Nos Actualités